Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor
Paul A. Dickinson(Quotient Clinical (United Kingdom)), Mireille Cantarini(Quotient Clinical (United Kingdom)), J. Collier(AstraZeneca (United Kingdom)), Paul Frewer(Quotient Clinical (United Kingdom)), Scott Martin(AstraZeneca (United Kingdom)), Kathryn Pickup(AstraZeneca (United Kingdom)), Peter Ballard(AstraZeneca (United Kingdom))
Cited by 129
Abstract
Related Papers
No related papers found
Powered by citation graph analysis